|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CH |
First Approval Date01 Jan 1984 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.US |
First Approval Date18 Sep 1986 |
中国健康受试者单次和多次给予美沙拉秦灌肠液(颇得斯安灌肠液)后的药代动力学和安全性的开放研究
[Translation] An open-label study of the pharmacokinetics and safety of mesalazine enema (Podesan enema) in healthy Chinese subjects after single and repeated administration
观察有多少新药进体内,比如药物浓度何时达到峰值以及峰值时多少
[Translation] Observe how much new drug enters the body, such as when and how much drug concentration peaks
一项随机、双盲、安慰剂对照、多中心的优效性试验用于评价颇得斯安灌肠剂的有效性和安全性
[Translation] A randomized, double-blind, placebo-controlled, multicenter superiority trial to evaluate the efficacy and safety of Podesan enema
研究在中国活动性左半结肠溃疡性结肠炎(UC)患者4周的治疗中,与安慰剂灌肠剂相比,颇得斯安灌肠剂(1 g/100 ml QD)的有效性和安全性,之后是最长28周的颇得斯安灌肠剂和/或颇得斯安片剂的开放性扩展期治疗
[Translation] To investigate the efficacy and safety of Podesan enema (1 g/100 ml QD) compared with placebo enema in Chinese patients with active left-sided ulcerative colitis (UC) for 4 weeks, followed by an open-label extension period of Podesan enema and/or Podesan tablets for up to 28 weeks.
对促性腺激素下调的中国女性健康受试者单次及多次皮下注射BRAVELLE后的药代动力学和安全性的开放研究
[Translation] An open-label study of the pharmacokinetics and safety of BRAVELLE following single and multiple subcutaneous injections in healthy Chinese female subjects with gonadotropin downregulation
为研究BRAVELLE在中国女性健康受试者中的单次和多次给药后的药代动力学
[Translation] To investigate the pharmacokinetics of BRAVELLE after single and multiple doses in healthy Chinese female subjects
100 Clinical Results associated with Hong Kong Ferring Pharmaceutical Co., Ltd. Beijing Representative Office
0 Patents (Medical) associated with Hong Kong Ferring Pharmaceutical Co., Ltd. Beijing Representative Office
100 Deals associated with Hong Kong Ferring Pharmaceutical Co., Ltd. Beijing Representative Office
100 Translational Medicine associated with Hong Kong Ferring Pharmaceutical Co., Ltd. Beijing Representative Office